“…Furthermore, in TAA and AAA, we identify distinct marker genes as potential regulators participating in the pathological process in both organisms. For example, both in h Fibromyocyte and m SMC3, we identify potential causative genes for AAA ( CXCL12 , MFAP5 , and EMP1 ), among which the blockade of CXCL12/CXCR4 protects against AAA formation ( Michineau et al, 2014 ), and distinct pathogenic genes for TAA [collagen genes ( COL1A1 , COL1A2 , COL3A1 , and COL5A2 ), some reported virulence genes for TAA ( LOX , COL3A1 , and MMP2 ) ( Longo et al, 2002 ; Shen et al, 2015 ; Pinard et al, 2019 ; Chen et al, 2022 ), and other unreported genes ( CTHRC1 , SERPINH1 , SPARC , THY1 , and CTSK )]. Among the genes we enriched, the presence of these proven disease-causing genes to some extent supported the validity of our analysis, and the role of these unreported genes deserved further investigation.…”